RS59725B1 - Postupak prečišćavanja za jedinjenja fosfaplatina - Google Patents

Postupak prečišćavanja za jedinjenja fosfaplatina

Info

Publication number
RS59725B1
RS59725B1 RS20191364A RSP20191364A RS59725B1 RS 59725 B1 RS59725 B1 RS 59725B1 RS 20191364 A RS20191364 A RS 20191364A RS P20191364 A RSP20191364 A RS P20191364A RS 59725 B1 RS59725 B1 RS 59725B1
Authority
RS
Serbia
Prior art keywords
pyrophosphate
dach
platinum
monomeric
solution
Prior art date
Application number
RS20191364A
Other languages
English (en)
Serbian (sr)
Inventor
Wayne D Luke
Steffen Jost
Original Assignee
Phosplatin Therapeutics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phosplatin Therapeutics Llc filed Critical Phosplatin Therapeutics Llc
Publication of RS59725B1 publication Critical patent/RS59725B1/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086Platinum compounds
    • C07F15/0093Platinum compounds without a metal-carbon linkage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
RS20191364A 2012-05-24 2013-03-15 Postupak prečišćavanja za jedinjenja fosfaplatina RS59725B1 (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261651200P 2012-05-24 2012-05-24
EP16203851.7A EP3202769B1 (en) 2012-05-24 2013-03-15 Purification method for phosphaplatin compounds

Publications (1)

Publication Number Publication Date
RS59725B1 true RS59725B1 (sr) 2020-01-31

Family

ID=49624225

Family Applications (2)

Application Number Title Priority Date Filing Date
RS20170272A RS55806B1 (sr) 2012-05-24 2013-03-15 Postupci sinteze i prečišćavanja za jedinjenja fosfaplatina i njihove upotrebe
RS20191364A RS59725B1 (sr) 2012-05-24 2013-03-15 Postupak prečišćavanja za jedinjenja fosfaplatina

Family Applications Before (1)

Application Number Title Priority Date Filing Date
RS20170272A RS55806B1 (sr) 2012-05-24 2013-03-15 Postupci sinteze i prečišćavanja za jedinjenja fosfaplatina i njihove upotrebe

Country Status (18)

Country Link
US (2) US8846964B2 (OSRAM)
EP (2) EP3202769B1 (OSRAM)
JP (1) JP5833795B2 (OSRAM)
CN (2) CN104540839B (OSRAM)
CY (2) CY1118746T1 (OSRAM)
DK (2) DK3202769T3 (OSRAM)
ES (2) ES2751668T3 (OSRAM)
HR (2) HRP20170416T1 (OSRAM)
HU (2) HUE046327T2 (OSRAM)
IN (1) IN2014KN02722A (OSRAM)
LT (2) LT2855496T (OSRAM)
PL (2) PL3202769T3 (OSRAM)
PT (2) PT3202769T (OSRAM)
RS (2) RS55806B1 (OSRAM)
SI (2) SI2855496T1 (OSRAM)
SM (2) SMT201900617T1 (OSRAM)
TW (2) TWI599361B (OSRAM)
WO (1) WO2013176764A1 (OSRAM)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3202769T (pt) * 2012-05-24 2019-10-31 Phosplatin Therapeutics Llc Processos de síntese e de purificação para compostos de fosfaplatina e aplicações dos mesmos
EA039525B1 (ru) * 2016-04-06 2022-02-07 Фосплатин Терапьютикс Инк. Фосфаплатиновые жидкие составы
EP3565561A4 (en) * 2017-01-06 2020-08-26 Phosplatin Therapeutics LLC PHOSPHAPLATIN COMPOUNDS AS THERAPEUTIC AGENTS FOR THE TREATMENT OF BLOOD AND BONE CANCERS
CN111328330B (zh) * 2017-09-08 2024-03-08 普罗蒙托里治疗有限公司 作为免疫调节剂的磷铂化合物及其治疗用途
CN113861036B (zh) * 2021-11-08 2024-04-02 合肥工业大学 一种乙二胺高氯酸铜配合物的制备及用途
US11673904B1 (en) * 2021-12-09 2023-06-13 L'air Liquide, Societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude Low pressure process for synthesis of Pt(PF3)4 involving a soluble intermediate and storage of obtained Pt(PF3)4
CN119822568B (zh) * 2025-02-19 2025-08-19 扬州宏鑫环保科技有限公司 一种高效纯化水制备装置及制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4234500A (en) 1979-03-07 1980-11-18 Engelhard Minerals & Chemicals Corporation Ethylenediamine platinum(II) and 1,2-diamino-cyclohexane platinum(II) pyrophosphate complexes
JP4463274B2 (ja) 2003-06-27 2010-05-19 明 小谷 ビスホスホネート錯体
JP2009525273A (ja) * 2006-01-30 2009-07-09 プラットコー テクノロジーズ (プロプライエタリー) リミテッド 白金(ii)錯体の調製
MX2009012273A (es) * 2007-05-18 2010-04-09 Tti Ellebeau Inc Dispositivos de suministro transd?rmico que aseguran la liberaci?n mejorada de un principio activo a trav?s de una interfaz biol?gica.
PT2173337E (pt) * 2007-08-06 2014-09-03 Univ Ohio Fosfoplatinas e a sua utilização no tratamento de cancros resistentes à cisplantina e carboplatina
SG185722A1 (en) * 2010-06-04 2013-01-30 Univ Ohio Phosphaplatins and their use for treatment of cancers
JP6027619B2 (ja) * 2011-10-05 2016-11-16 ラシンドラ・エヌ・ボーズ ホスファプラチン系抗腫瘍剤の大規模調製のための効率的プロセス
PT3202769T (pt) * 2012-05-24 2019-10-31 Phosplatin Therapeutics Llc Processos de síntese e de purificação para compostos de fosfaplatina e aplicações dos mesmos

Also Published As

Publication number Publication date
SI2855496T1 (sl) 2017-04-26
TW201741326A (zh) 2017-12-01
ES2751668T3 (es) 2020-04-01
JP2015523335A (ja) 2015-08-13
HRP20170416T1 (hr) 2017-05-19
ES2619412T3 (es) 2017-06-26
TW201347765A (zh) 2013-12-01
HK1203202A1 (en) 2015-10-23
SMT201700168T1 (it) 2017-05-08
RS55806B1 (sr) 2017-08-31
CN104540839A (zh) 2015-04-22
US20140024848A1 (en) 2014-01-23
EP2855496A4 (en) 2015-04-08
US8859796B1 (en) 2014-10-14
PT2855496T (pt) 2017-03-23
LT3202769T (lt) 2019-12-10
TWI599361B (zh) 2017-09-21
US8846964B2 (en) 2014-09-30
HUE046327T2 (hu) 2020-03-30
CN106967124A (zh) 2017-07-21
PL2855496T3 (pl) 2017-09-29
DK3202769T3 (da) 2019-10-28
EP2855496A1 (en) 2015-04-08
CY1118746T1 (el) 2018-03-07
DK2855496T3 (en) 2017-03-27
PL3202769T3 (pl) 2020-03-31
US20140288321A1 (en) 2014-09-25
PT3202769T (pt) 2019-10-31
CN106967124B (zh) 2020-03-06
IN2014KN02722A (OSRAM) 2015-05-08
CY1122316T1 (el) 2021-01-27
LT2855496T (lt) 2017-04-10
EP3202769A1 (en) 2017-08-09
EP2855496B1 (en) 2016-12-14
TWI653237B (zh) 2019-03-11
SMT201900617T1 (it) 2020-01-14
EP3202769B1 (en) 2019-10-02
WO2013176764A1 (en) 2013-11-28
HUE032197T2 (en) 2017-09-28
SI3202769T1 (sl) 2020-02-28
CN104540839B (zh) 2017-02-22
HRP20191904T1 (hr) 2020-01-24
JP5833795B2 (ja) 2015-12-16

Similar Documents

Publication Publication Date Title
RS59725B1 (sr) Postupak prečišćavanja za jedinjenja fosfaplatina
US7956208B2 (en) Preparation of platinum (II) complexes
CN106146560B (zh) 一种高纯度磷酸特地唑胺的精制方法
CN102531988A (zh) 一种左旋奥拉西坦的纯化方法
WO2019161526A1 (zh) 一锅法制备双二羧酸二氨络铂(ii)衍生物的方法
CN104086592B (zh) 一种磷霉素氨丁三醇的制备方法
CN104119387B (zh) 一种米铂的制备方法
CN101723988B (zh) 一种杂质含量极低的奥沙利铂的制备方法
US10100055B2 (en) Imidazopyrroloquinoline salt, method for producing the same, medicament, cosmetic, and food
CN114555557A (zh) 森塔纳法啶的制备方法
HK1240939A1 (en) Purification method for phosphaplatin compounds
HK1240939B (en) Purification method for phosphaplatin compounds
HK1203202B (en) Synthetic and purification methods for phosphaplatin compounds and uses thereof
RU2432351C1 (ru) Способ получения 4-нитростирола
CA2934535A1 (en) Large scale manufacture of 2,4-pyrimidinediamines and intermediates
Lee Chiral Behavior of S-Bridged M3M’2 (M= AuI